»ï¼ºº´¿ø Á¦12ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2020-01-18±³À°ÀÏÀÚ : 2020-01-18
±³À°Àå¼Ò : »ï¼ºº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
Á¦12ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺ¹¸·¾ÏÇÐȸ
´ã´çÀÚ : ±èÇöÁ¤
¿¬¶ôó : 041-529-6186
À̸ÞÀÏ :
office@kspsm.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, »êºÎÀΰú, Á¤½Å°Ç°ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í »çÀüµî·Ï 4¸¸¿ø, ÇöÀåµî·Ï 5¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-18 ´ë°´ç 09:10~09:30 Histology and pathology of the peritoneum Áø¼ºÈ£(¿øÀڷº´¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 09:30~09:50 Molecular mechanism of peritoneal metastases Yonemura(Japan-Tokyo)
±³À°½Ã°£ 01-18 ´ë°´ç 09:50~10:10 Animal models of peritoneal metastases ¹ÚÀºÁ¤(°³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 10:10~10:30 Immunotherapy ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 01-18 ´ë°´ç 10:30~10:50 PIPAC ¹Î»çÈ«(ºÐ´ç¼¿ïº´¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 10:50~11:10 Precision medicine in peritoneal metastases TBD()
ÈÞ½Ä 01-18 ´ë°´ç 11:10~11:30 Coffee Break ()
±³À°½Ã°£ 01-18 ´ë°´ç 11:30~12:00 Future perspective of the CRS/HIPEC as treatment modality for peritoneal surface malignancy ¹Ú»óÀ±(±¹¸³¾Ï¼¾ÅÍ)
½Ä»ç 01-18 ´ë°´ç 12:00~13:00 Á¡½É ()
±³À°½Ã°£ 01-18 ´ë°´ç 13:10~13:30 PIPS-GC trial ¼¿øÁØ(°í·Á´ëº´¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 13:30~13:50 COLOPEC and COMBATAC, PRODIGE 7 and ProphyloCHIP ÀÌ¿ø¼®(°¡Ãµ´ë±æº´¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 13:50~14:10 PHEONIX-GC trial Ishigami(Japan-Tokyo)
±³À°½Ã°£ 01-18 ´ë°´ç 14:10~14:30 OVHIPEC and TBD Àå¼®ÁØ(¾ÆÁִ뺴¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 14:30~14:50 Nutritional therapy to prevent sarcopenia ¼³Áö¿µ(Ãæ³²´ëº´¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 14:50~15:10 Psychologic support À±¼¼Ã¢(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 15:10~15:30 Pain control ½Åµ¿¿í(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 15:30~15:50 Radiologic intervention ¼Û¿ëÁß(ºÎ»ê´ëº´¿ø)
±³À°½Ã°£ 01-18 ´ë°´ç 15:50~16:10 Tumor board or oral presentation ()